Europe Colorectal Cancer Diagnostics Market to 2032
Overview
The Europe Colorectal Cancer Diagnostics Market is expected to reach a 2.05 USD Billion by 2032 and is projected to grow at a CAGR of 11.19% from 2025 to 2032.
Europe Colorectal Cancer Diagnostics Market 2018-2032 USD Billion
Europe Colorectal Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.13 USD Billion
- Projected Market Size (2032): 2.05 USD Billion
- CAGR (2025-2032): 11.19%
Key Findings of Europe Colorectal Cancer Diagnostics Market
- The Europe Colorectal Cancer Diagnostics Market was valued at 1.13 USD Billion in 2024.
- The Europe Colorectal Cancer Diagnostics Market is likely to grow at a CAGR of 11.19% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Instruments in Product Type Segment accounted for the largest share of the market with a revenue of 0.77 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 14.50% during the forecast period from 2024 to 2032.
Europe Colorectal Cancer Diagnostics Market Scope
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
- Pediatric
- Adults
- Geriatric
- Consumables & Accessories
- Instruments
Europe Colorectal Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.13 USD Billion |
| Market Value in 2032 | 2.05 USD Billion |
| CAGR (2025-2032) | 11.19% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Test Type,Cancer Stages,Cancer Type,Age Group,Product Type |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 1.13 USD Billion in 2024
- Key Country: Germany, leading in terms of revenue with value of 212.97 USD Million in 2024.
Segments and Scope
-
Europe Colorectal Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a revenue of 352.05 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 14.50 % in forecast period 2025-2032.
-
Europe Colorectal Cancer Diagnostics Market to 2032, By Test Type
- Stool Examination is the largest segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a revenue of 449.13 USD Billion in the year 2024.
- Stool Examination is the Fastest growing segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 13.69 % in forecast period 2025-2032.
-
Europe Colorectal Cancer Diagnostics Market to 2032, By Cancer Stages
- Stage III is the largest segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a revenue of 471.59 USD Billion in the year 2024.
- Stage III is the Fastest growing segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 13.85 % in forecast period 2025-2032.
-
Europe Colorectal Cancer Diagnostics Market to 2032, By Cancer Type
- Adenocarcinoma is the largest segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a revenue of 702.02 USD Billion in the year 2024.
- Adenocarcinoma is the Fastest growing segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 12.13 % in forecast period 2025-2032.
-
Europe Colorectal Cancer Diagnostics Market to 2032, By Age Group
- Geriatric is the largest segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a revenue of 532.76 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 12.68 % in forecast period 2025-2032.
-
Europe Colorectal Cancer Diagnostics Market to 2032, By Product Type
- Instruments is the largest segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a revenue of 765.16 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in Europe Colorectal Cancer Diagnostics Market to 2032 with a Growth rate of 12.56 % in forecast period 2025-2032.
Europe Colorectal Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Illumina, Inc. | |||
| Koninklijke Philips N.V. | |||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
Europe Colorectal Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
Europe Colorectal Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Europe Colorectal Cancer Diagnostics Market Scope
- Others
- Academic Institutes
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
- Others
- Biopsy
- Tumor Markers
- Imaging Test
- Blood Test
- Stool Examination
- Stage 0
- Stage I
- Stage II
- Stage IV
- Stage III
- Others
- Carcinoid Tumors
- Gastrointestinal Stromal Tumors
- Colorectal Lymphoma
- Adenocarcinoma
- Pediatric
- Adults
- Geriatric
- Consumables & Accessories
- Instruments
Frequently Asked Questions
Europe Colorectal Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.